# Insulin Lispro

NDC: 50090-5391
Generic name: Insulin lispro
Labeler / Manufacturer: A-S Medication Solutions
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20200212

FDA application: BLA020563

## Active ingredients

- INSULIN LISPRO: 100 [iU]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50090-5391"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50090-5391
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2be14cbb-197a-4da8-82c8-2443594e7f6f